Cargando…
Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292509/ http://dx.doi.org/10.1186/2051-1426-2-S3-P231 |
| _version_ | 1782352491119116288 |
|---|---|
| author | Pico de Coaña, Yago Poschke, Isabel Yoshimoto, Yuya Karlberg, Sara Nyström, Maria Wolodarski, Maria Hansson, Johan Masucci, Giuseppe Kiessling, Rolf |
| author_facet | Pico de Coaña, Yago Poschke, Isabel Yoshimoto, Yuya Karlberg, Sara Nyström, Maria Wolodarski, Maria Hansson, Johan Masucci, Giuseppe Kiessling, Rolf |
| author_sort | Pico de Coaña, Yago |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4292509 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42925092015-01-15 Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients Pico de Coaña, Yago Poschke, Isabel Yoshimoto, Yuya Karlberg, Sara Nyström, Maria Wolodarski, Maria Hansson, Johan Masucci, Giuseppe Kiessling, Rolf J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4292509/ http://dx.doi.org/10.1186/2051-1426-2-S3-P231 Text en Copyright © 2014 Pico de Coaña et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Pico de Coaña, Yago Poschke, Isabel Yoshimoto, Yuya Karlberg, Sara Nyström, Maria Wolodarski, Maria Hansson, Johan Masucci, Giuseppe Kiessling, Rolf Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title | Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title_full | Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title_fullStr | Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title_full_unstemmed | Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title_short | Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients |
| title_sort | ipilimumab treatment enhances cd4+ t cell activation while decreasing treg and mdsc frequency in advanced melanoma patients |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292509/ http://dx.doi.org/10.1186/2051-1426-2-S3-P231 |
| work_keys_str_mv | AT picodecoanayago ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT poschkeisabel ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT yoshimotoyuya ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT karlbergsara ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT nystrommaria ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT wolodarskimaria ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT hanssonjohan ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT masuccigiuseppe ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients AT kiesslingrolf ipilimumabtreatmentenhancescd4tcellactivationwhiledecreasingtregandmdscfrequencyinadvancedmelanomapatients |